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Background. Guanylyl cyclases (GCs) catalyze the formation of the second messenger guanosine 39,59-cyclic monophosphate
(cGMP) from guanosine 59-triphosphate (GTP). Cyclic GMP has been implicated in an increasing number of plant processes,
including responses to abiotic stresses such as dehydration and salt, as well as hormones. Principle Findings. Here we used
a rational search strategy based on conserved and functionally assigned residues in the catalytic centre of annotated GCs to
identify candidate GCs in Arabidopsis thaliana and show that one of the candidates is the brassinosteroid receptor AtBR1,
a leucine rich repeat receptor like kinase. We have cloned and expressed a 114 amino acid recombinant protein (AtBR1-GC)
that harbours the putative catalytic domain, and demonstrate that this molecule can convert GTP to cGMP in vitro.
Conclusions. Our results suggest that AtBR1 may belong to a novel class of GCs that contains both a cytosolic kinase and GC
domain, and thus have a domain organisation that is not dissimilar to that of atrial natriuretic peptide receptors, NPR1 and
NPR2. The findings also suggest that cGMP may have a role as a second messenger in brassinosteroid signalling. In addition, it
is conceivable that other proteins containing the extended GC search motif may also have catalytic activity, thus implying that
a significant number of GCs, both in plants and animals, remain to be discovered, and this is in keeping with the fact that the
single cellular green alga Chlamydomonas reinhardtii contains over 90 annotated putative CGs.
Citation: Kwezi L, Meier S, Mungur L, Ruzvidzo O, Irving H, et al (2007) The Arabidopsis thaliana Brassinosteroid Receptor (AtBRI1) Contains a Domain
that Functions as a Guanylyl Cyclase In Vitro. PLoS ONE 2(5): e449. doi:10.1371/journal.pone.0000449
INTRODUCTION
Guanylyl cyclases (GCs) have been identified in many diverse
prokaryotes and eukaryotes where they catalyse the formation of
the second messenger guanosine 39,59-cyclic monophosphate
(cGMP) from guanosine 59-triphosphate (GTP) [1]. In higher
plants cGMP has been shown to act as a second messenger in
a large number of physiological responses [2,3] that include
cGMP-mediated changes of the transcriptome [4], NO-dependent
signaling [5] as well as gravitropic responses [6] and plant
hormone-dependent responses [7–9]. Furthermore, significant and
transient increases in intracellular cGMP levels have also been
reported in response to plant natriuretic peptides (PNPs) [8,10] as
well as NaCl and drought stress [11]. The first functional GC in
higher plants was identified with a search motif based on several
functionally assigned amino acids in the catalytic domain of known
GCs from lower eukaryotes and animals [12].
Here we show that a rationally designed search motif of the
catalytic domain identifies several members of the family of leucine
rich repeat receptor-like kinases (LRR RLKs) including an
Arabidopsis thaliana brassinosteroid receptor (AtBRI1). A recombi-
nant domain protein was made which tested positive for GC
activity in vitro. The implications of this finding for both the
projected number of different classes of GCs and the role of cGMP
in brassinosteroid signaling are discussed.
RESULTS
Extending the search GC search motif and
identification of AtBRI1
The original GC search motif [RKS][YFW][GCTH][VIL][FV]-
X[DNA]X[VIL]X{4}[KR] [12] (Figure 1A) yielded seven
Arabidopsis candidate proteins including AtGC1 that has been
demonstrated to have GC activity in vitro [12]. Two of seven
proteins are annotated kinases and one of the two (At1g79680)
belongs to the group of wall associated kinase-like proteins
(WAKLs). In a quest to identify further candidate GCs in plants
we mutated the position 7 in the original search motif. This
position is assigned as having a role in dimerisation that may not
be a critical requirement for GC functionality. When [D] in
position 7 is substituted by [L] in a 100 amino acid recombinant
AtGC1(1–100), a domain that is encoded by the first exon of
AtGC1 (Figure 1B), no significant loss in catalytic GC activity
occurs (Fig. 1D). This implies firstly that a 100 amino acid domain
is sufficient for activity and secondly, that [D] in position 7 is not
essential for AtGC1 GC activity. These observation may hold for
a number of GCs. Consequently we added [L] to make position 7
[DNAL] (Fig. 2A). This extended motif retrieves 123 Arabidopsis
thaliana proteins including the brassinosteroid receptor AtBRI1
(Arabidopsis thaliana brassinosteroid insensitive 1 (NP_195650.1,
At4g39400.1). Furthermore, since the catalytic asparagine [N] in
position 10, while quite conserved in some classes of nucleotide
cyclases is substituted by [AILSTYHDE] in many annotated GCs
[13], we further modified the motif to [RKS][YFW][GCTH][-
VIL][FV]X{3}[VIL]X{4}[KR].Allthree motifsarespecificforGC
Academic Editor: Ivan Baxter, Purdue University, United States of America
Received February 26, 2007; Accepted April 19, 2007; Published May 23, 2007
Copyright:  2007 Kwezi et al. This is an open-access article distributed under
the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: This work was supported by the NRF (South Africa) and the ARC
(Australia).
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: cgehring@uwc.ac.za
PLoS ONE | www.plosone.org 1 May 2007 | Issue 5 | e449rather than adenylyl cyclases (ACs) since they contain the residues
[GCTH] in position 3 facing the purine and determining substrate
specificity for GTP rather than ATP [13–15] and GenBank contains
no annotated ACs that conform to either of the motifs.
The third and most relaxed motif appears in 171 Arabidopsis
proteins of which 88 contain [EQCTDRVHY] at position 16 or
17 which is presumed responsible for metal ion binding [13].
Metal binding is normally associated with aspartic or glutamic acid
([DE]). Within the group of 88 proteins; 27 contain a PPi-binding
[R] between 5 and 20 amino acids N-terminal of the core motif.
These 27 Arabidopsis proteins (Table 1) represent a highly
significant (p,1e
25) enrichment for the gene ontology GO
categories of phosphorus metabolic processes, protein metabolic
process, cellular macromolecular metabolic process and bio-
polymer metabolic process. It is noteworthy that several are
annotated as leucine rich repeat receptor like kinases (LRR RLKs)
including AtBRI1 (Fig. 2). In AtBRI1, the putative catalytic core
was identified within the cytosolic kinase domain.
The choice of for further testing AtBRI1 was informed by
several factors including the fact that brassinosteroids are
physiologically well characterised growth regulators that await
further elucidation of their signal transduction networks as well as
the availability of a number of AtBRI1 mutants that can support
these investigations. Brassinosteroid receptors have been identified
in several other species and these also contain the conserved GC
motif (Fig. 2D).
The recombinant protein that we decided to synthesise and test
for in vitro activity contains the predicted GC catalytic centre of
AtBRI1 (At4g39400) and 50 additional amino acids on both the
N- and the C-terminus (Fig. 2C). This peptide (AtBRI1-GC) is
part of the cytoplasmic domain containing the N-terminal part
aspartic acid ([D] at 233 from the catalytic centre) implicated in
Figure 1. Site-directed mutagenesis and functional testing of AtGC1(1–100). (A) Original 14 amino acid search motif for GCs [12]; substitutions are
in square brackets, X represents any amino acid and curly brackets define the number of amino acids. (B) AtGC1 (At5g05930): The position of the GC
catalytic centre is marked in red; the underlined aspartic acid [D] is the amino acid that has been changed into a leucine [L] by site directed
mutagenesis. The open arrow marks the conserved PPi-binding arginine [R] and the C-terminal putative metal binding site is highlighted in
aquamarine. The green triangles point to exon borders and the solid arrow shows the border of the fragment that we have tested for GC activity. (C)
SDS-PAGE of the 3 purification steps of the recombinant protein AtGC1(1–100); ‘‘M’’ is the molecular weight marker, ‘‘FT’’ is the protein in the flow-
through, ‘‘W’’ is the wash and ‘‘E’’ is the eluted recombinant protein. (D) In vitro GC activity assay. The control (cont.; empty bar) was obtained by
omitting protein in the reaction mix and the concentration of GTP was 1mM and that of Mn
2+ or Mg
2+ was 5 mM. The values for the wild-type protein
(N-terminal fragment of 100 amino acids containing a [D] in position 7 of the catalytic centre) and the mutated protein (N-terminal fragment of 100
amino acids containing [L] in position 7 of the catalytic centre) are represented with solid bars. The bar values represent the mean cGMP (+/2SEM)
generated in 15 minutes in three samples and the response pattern is representative of 3 independent experiments.
doi:10.1371/journal.pone.0000449.g001
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relative to the C-terminus of the motif.
Testing a recombinant GC domain (AtBRI1-GC) for
activity
The capacity of the recombinant putative GC domain of AtBRI1
(AtBRI1-GC) to generate cGMP from GTP was assessed with two
independent methods. Firstly, we used an enzyme immunoassay to
check if a reconstituted recombinant AtBRI1-GC could function as
aG Cin vitro. The results indicate that the recombinant protein can
cyclaseGTPanddoessopreferablyinthepresenceofMg
2+(Fig.3A).
In order to verify the result obtained with this anti-body based
detection method we also used mass spectrometry. Firstly, we
established that the Q-TOF mass chromatogram could detect
cGMP at fmol concentrations (Fig. 3D, right inset) much like the
enzyme immunoassay. We detected neither cGMP in the solution
containing the recombinant proteinonly (Fig.3B) norinthe reaction
mix in the absence of the protein (Fig. 3C). Our sample generates
cGMP in a time dependent way (Fig. 3D). We calculated that after
5 min. incubation in the presence of 1 mM GTP 100 fmoles
cGMP/mg protein were generated and after 20 min. .3 pmoles
cGMP/mg protein (Fig. 3D). We noted that values of the amount of
cGMP generated obtained with the mass spectroscopy read higher
than those obtained with the enzymatic assay and this observation
has been made consistently in independent in vitro experiments with
recombinant proteins (data not shown). In addition, it is noteworthy
that plant GC activities are reportedly low and certainly not at the
levels observed for some soluble animal GCs [17]. The main reason
for this is that higher activities might require co-factors (e.g. Ca
2+,
chaperones or co-proteins) or post-translational modifications that
are not present in the recombinant tested in vitro.
We also used mass spectrometry to test AtBRI1-GC for adenylyl
cyclase activity in the presence of 1 mM ATP as the substrate and
could not detect significant amounts of cAMP generated after
20 min. of incubation (result not shown) thus indicating that, at
least in vitro, the recombinant protein has the predicted substrate
preference for GTP.
Figure 2. Structural features of the GC catalytic domain and the Arabidopsis thaliana brassinosteroid receptor AtBRI1. (A) The 14 amino acid long
original search motif (modified after [12] with an inclusion of [L] in position 7). Red amino acids are functionally assigned residues of the catalytic
centre. The residue in position 1 does the hydrogen bonding with the guanine, the amino acid in position 3 confers substrate specificity and the
residues in positions 10 and 14 stabilise the transition (GTP/cGMP). (B) Representation of the domain organisation of AtBRI1 containing a signal
peptide (SP), leucine rich repeats (LLRs) including an island, a transmembrane domain (TM), a GC centre embedded in the kinase domain. The
position (16 or 17) outside the catalytic centre is implicated in Mg
2+/Mn
2+-binding (aquamarine). (C) Amino acid sequence of the intracellular C-
terminal region of AtBRI1. The kinase domain is underlined (yellow), the GC domain is boxed in green, putative Mg
2+/Mn
2+-binding sites are
highlighted (aquamarine), the proposed PPi binding is underlined in black, and the recombinant protein (AtBRI1-GC) tested for GC activity in vitro is
delineated by solid triangles (s). (D) Alignment of AtBRI1-like sequences. AtBRI1 (At4g39400), LeBRI1 (tomato|TC185049, Q9LJF3), OsBRI1
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Brassinosteroids (BRs) are polyhydroxylated plant steroid hor-
mones with an essential role in co-regulating many processes
including embryogenesis, cell elongation and vascular differenti-
ation [25,26]. Brassinosteroid Insensitive-1 (BRI1) was first
identified from mutant analysis and then cloned and found to be
a leucine rich repeat receptor like kinase [27] located in the plasma
membrane [28,29]. Based on the binding of the ligand BR to the
leucine rich repeat extracellular domain, BRI1 has been identified
as a BR receptor in Arabidopsis [29,30] and therefore a critical
signal component. BRI1 is ubiquitously expressed in Arabidopsis
and potential BRI1 kinase substrates have been identified such as
transthyretin-like protein which is phosphorylated in vitro by the
kinase domain of BRI1 [31]. Several models have been developed
to describe the signaling events following perception of BR by
BRI1 (see [32]) involving other membrane associated proteins and
activation of transcription factors. The observation that AtBRI1
does harbor a functional GC domain within the cytosolic part of
the molecule might suggest that cGMP is a second messenger in
some BR dependent processes. However, this hypothesis remains
to be tested. Several genes that regulate physiological functions are
stimulated by BR as well as being influenced by cGMP. An
example for this dual dependence is plant cell elongation [26].
Microarray studies revealed that genes involved in cell wall
expansion such as expansins and pectinesterases are up-regulated
by both BR [32] and membrane permeable cGMP treatments [4].
Both BR and gibberellin interact to regulate plant growth. Some
of these interactions are antagonistic but in other cases, BR can
potentiate gibberellin activity [33]. Gibberellin, itself, stimulates
increases in cGMP [7]. It is conceivable that in some instances the
GC domain of BRI1 could stimulate cGMP production and so
potentiate gibberellin activity. On a speculative note, there may be
key molecules within specific cells that specify decreased cytoplasmic
kinase activity and enhance the GC activity of the AtBRI1.
There are several recessive alleles of AtBRI1 in the cytoplasmic
kinase domain. Of these mutants, bri-101 is the only mutant in the
GC catalytic region ([E] 1078 to [L]) and it is insensitive to BR
and also has reduced kinase activity when tested in a heterologous
system [27,28]. Interestingly, this mutation should not affect the
GC activity as it occurs at position 8 which can be any amino acid.
Three other mutants have been found in the region that we show
confers GC activity in vitro, being: bri-103,104 [A] 1031 to [T],
bri1-105-107 [Q] 1059 to stop (which would exclude the GC
catalytic domain from the truncated protein) and bri1-115 [G]
1048 to [N] [28]. The domain that we have identified (Fig. 2)
occurs within the kinase domain [28]. We demonstrate that the
isolated 114 amino acid recombinant peptide (AtBRI1-GC) has
GC activity in vitro (Fig. 3). The relative importance of the two
functions in the action of the receptor remains to be demonstrated
bearing in mind that previously work has focused on the kinase
domain as the GC domain had not been identified. Interestingly,
a number of enzymes have recently been identified as ‘‘moon-
lighting’’ proteins with dual functions [34]; the kinase and GC
activity of AtBRI1 could be yet another example.
On a more general level, the finding implies that functional GC
domains may be part of a large variety of different multifunctional
signaling molecules and receptors in particular. It is noteworthy
that the atrial natriuretic peptide receptors NPR1 and NPR2 both
signalthrough cGMPand have anAtBRI1-like domainorganisation
with an extracellular ligand-binding domain, a transmembrane
domain and an intracellular kinase and GC domain [35,36].
Finally, the fact that two recombinant proteins (AtGC1(1–100)
and AtBRI1 - GC ) of less than 120 amino acids have GC activity
in vitro begs a reexamination of the minimal catalytic requirement
for GCs and may suggest that the number of different GC
domains is significantly higher than currently assumed. This is in
keeping with the fact that the single cellular green alga
Chlamydomonas reinhardtii contains a surprisingly large number
(.90) of annotated putative GCs [1] and with the increasing
number of biological processes discovered that are modulated by
the second messenger cGMP [2,3].
MATERIALS AND METHODS
Identification of GC catalytic domain
Annotated GCs were retrieved from NCBI and their catalytic
domains [13] were used for Blast [37] queries of ‘‘The Arabidopsis
Information Resource’’ (TAIR) database and GenBank. The
catalytic domains were aligned using Clustal X [38] and the
alignments at the catalytic centre of the catalytic domain was used
to derive the search motifs [12]. Derived search motifs were tested






At1g14370 Protein kinase APK2a
At1g17750 Leucine-rich repeat transmembrane protein kinase
At1g28440 Leucine-rich repeat transmembrane protein kinase
At1g48220 Serine/threonine protein kinase, similar to Pto kinase interactor
At1g69270 Leucine-rich repeat family protein, protein kinase family
At1g69910 Protein kinase family protein
At1g73080 Nucleotide binding leucine-rich repeat RK, immune response
At1g76370 Protein kinase
At2g01860 Pentatricopeptide (PPR) repeat-containing protein
At2g02800 Protein kinase APK2b
At2g26330 Leucine-rich repeat protein kinase, putative ERECTA
At2g32800 Kinase family protein with dual protein kinase domains
At3g02130 Leucine-rich repeat transmembrane protein kinase
At3g02810 Protein kinase family protein
At3g07070 Protein kinase family protein
At3g24790 Protein kinase family protein
At3g46340 Leucine-rich repeat protein kinase, similar to light repressible
receptor PK
At3g46350 Leucine-rich repeat protein kinase
At3g46400 Leucine-rich repeat protein kinase, similar to light repressible
receptor PK




At5g07180 Leucine-rich repeat protein kinase, putative ERECTA
At5g10530 Lectin protein kinase, similar to receptor lectin kinase 3
At5g16500 Protein kinase family protein
At5g62230 Leucine-rich repeat protein kinase, putative ERECTA
PK, protein kinase; RK, receptor kinase. Note: The listed proteins constitute
a significant overrepresentation (p,1e
25) in the Fatigo+ (level 4) categories of
phosphorus metabolic processes, protein metabolic process, cellular
















































































































































PLoS ONE | www.plosone.org 4 May 2007 | Issue 5 | e449for accurate and specific detection of nucleotide cyclases by
querying the Protein Information Resource (www-nbrf.george-
town.edu) using the Pattern Match option on the PIR-NREF link.
Search motifs were also used to query the Arabidopsis genome via
the Arabidopsis server (www.arabidopsis.org) using the ‘‘Pat-
match’’ function.
Site-directed mutagenesis
A non-methylated double strand was synthesized using 0.5 mM
Forward (59 -ATACTGCCTATTCGATCTTCCCTTGGTGA-
GTGATG- 39) and 0.5 mM Reverse (59 – CATCACTCACCA-
AGGGAAGATCGAATAGGCAGTAT- 39) primers from a clone
Figure 3. Preparation of recombinant AtBRI1-GC and functional testing in vitro. (A) Testing of GC activity with an enzyme immunoassay. The
control contains the reaction mixture without the substrate (10 mg recombinant protein in 50 mM Tris-HCl (pH 7.5), 2 mM isobutyl methylxanthine
(IBMX), 5 mM Mg
2+ and 5 mM Mn
2+), the other columns represent cGMP generated in the presence of 1 mM GTP and either Mn
2+ or Mg
2+ after
20 min. The bar values represent the mean (+/2SEM). (B) Extracted mass chromatogram of m/z 344 [M-1]
21 ion of cGMP generated by 10 mg
recombinant protein. The inset shows an SDS-PAGE of AtBRI1-GC expressed in E. coli BL21 (pLysS) (DE3) and purified with Ni-NTA agarose under
denaturing conditions. Cleared lysate (lane 1), flow through (lane 2), first wash (lane 3), second wash (lane 4) and eluted recombinant protein (lane 5).
‘M’ is the molecular weight marker. (C) Extracted mass chromatogram of m/z 344 [M-1]
21 ion of the reaction mix without AtBRI1-GC. (D) Two
superimposed extracted mass chromatogram of m/z 344 [M-1]
21 ion of cGMP generated by 10 mg recombinant protein after 5 and 20 min.
respectively in the presence of 5 mM Mg
2+. (Note that the sample was diluted 200 times as compared to the experiment presented in Fig. 2A). The
left inset represents the mass of the peak in the chromatogram, the right inset is the calibration curve with 1.25, 10 and 50 fmoles on the column.
doi:10.1371/journal.pone.0000449.g003
Brassinosteroid Receptor
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mutagenesis occurred is underlined. Phusion High-Fidelity DNA
Polymerase (New England Biolabs) was used in accordance with
the manufactures instructions to amplify the plasmid. The original
methylated template plasmid was digested using DpnI (New
England Biolabs) leaving the amplified plasmid which was
transformed into E. coli Topo 10F competent cells (Invitrogen).
Single colonies were selected and the clones were analyzed by
DNA sequencing.
Synthesis of recombinant protein
Since no introns are in the putative GC domain of AtBRI1,
genomic DNA from Arabidopsis thaliana (Col.) was used as the PCR
template. PCR amplifications of AtBRI1 GC domain
(At4g39400.1: 3132–3638) (Forward primer with BamH11 site:
59 GCTAGGATCCTGGAAGCTCGGGTTT 39, reverse primer
with EcoR1 site: 59 TCCAGAATTCTCAAGCAACTTT-
TAAATGT 39) were performed on a Mastercycler personal
(Eppendorf, 22339 Hamburg Germany), in five 50 mL reaction
volumes. Each reaction contained 1.5 mM MgCl2, 200 mM
dNTPs, 0.5 mM reverse and forward primer, 7.4 ng of genomic
DNA, and 2.5 units of Taq polymerase (Fermentas GmbH, St.
Leon-Rot, Germany). The thermal cycling parameters were: initial
denaturation at 96uC for 3 min., followed by 30 sec. at 96uC,
50uC for 45 sec. and 72uC for 1 min. for 32 cycles, followed by
a final extension at 72uC for 10 min. A fragment of 340 bp was
excised from the gel and purified using the GFX purification kit as
per manufacturer’s instruction (Amersham Biosciences, Little
Chalfont, UK). The fragment was cloned into the pCRHT7
TOPOH-NT vector (Invitrogen Ltd., Paisley, UK) and used to
transform E. coli BL21 (DE3) pLysS cells (Invitrogen Ltd., Paisley,
UK); colonies were selected and inserts verified by sequencing.
cGMP measurements
GC activity in vitro was assessed by measuring cGMP generated
from GTP in the presence of 10 mg purified protein, 50 mM Tris-
HCl (pH 7.5), 2 mM isobutyl methylxanthine (IBMX), 5 mM
Mg
2+ and/or 5 mM Mn
2+ and 1 mM GTP [39]. Product levels
were measured by cGMP enzyme immunoassay Biotrak (EIA)
System (Amersham Biosciences, Little Chalfont, UK) with the
acetylation protocol as described in the supplier’s manual. The
anti-cGMP antibody is highly specific for cGMP and has
approximately 10
6 times lower affinity for cAMP.
Mass spectroscopic determinations of cGMP were done with
a Waters API Q-TOF Ultima in the W-mode. The samples were
introduced with a Waters Acquity UPLC (Waters Microsep,
Johannesburg, South Africa) at a flow rate of 180 mL/min. and
separation was achieved by a Phenomenex Synergi (Torrance,
CA) 4 mm Fusion -RP (25062.0 mm) column. A gradient of
solvent ‘‘A’’ (0.1% formic acid) and solvent ‘‘B’’ (100%
acetonitrile) over 18 min was applied. During the first 7 min.
the solvent composition was kept at 100% ‘‘A’’ followed by a linear
gradient of 3 min. to 80% ‘‘B’’ and re-equilibration to the initial
conditions. Electrospray ionisation in the negative mode was used
at a cone voltage of 35 V. The running parameters were optimised
for sensitivity and specificity.
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